In 2025, the top product, Austedo, generated revenues of around ****Â billion U.S. dollars. Teva Pharmaceutical Industries is one of the largest generic drug manufacturers in the world.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Teva Pharmaceutical, & U.S. Securities and Exchange Commission. (February 3, 2026). Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2025 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 31, 2026, from /statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/
Teva Pharmaceutical, und U.S. Securities and Exchange Commission. "Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2025 (in million U.S. dollars)." Chart. February 3, 2026. ÌÇÐÄÆÆ½â°æ. Accessed July 31, 2026. /statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/
Teva Pharmaceutical, U.S. Securities and Exchange Commission. (2026). Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2025 (in million U.S. dollars). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 31, 2026. /statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/
Teva Pharmaceutical, and U.S. Securities and Exchange Commission. "Leading Specialty Medicines of Teva Pharmaceutical Industries by Revenue from 2022 to 2025 (in Million U.S. Dollars)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 3 Feb 2026, /statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/
Teva Pharmaceutical & U.S. Securities and Exchange Commission, Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2025 (in million U.S. dollars) ÌÇÐÄÆÆ½â°æ, /statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/ (last visited July 31, 2026)
Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2025 (in million U.S. dollars) [Graph], Teva Pharmaceutical, & U.S. Securities and Exchange Commission, February 3, 2026. [Online]. Available: /statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/